People can now apply to become a member of the nation’s first government panel dedicated to studying the impact of psychedelic policy reform efforts.
Denver became the first city in the U.S. to make psilocybin offenses the lowest law enforcement priority in May, sparking a nationwide movement to reform laws governing psychedelics. As part of that voter-approved initiative, the city was required to establish a panel designed to “assess and report on the effects of the ordinance.”
On Wednesday, the city government opened an application portal for individuals interested in joining the body.
The Psilocybin Mushroom Policy Review Panel will comprised of eleven people, mostly appointed by the mayor. Two members must come from the City Council, one must be a harm reduction advocate, two must be a representatives of the local sheriff’s department and Denver Police Department, one must be a criminal defense attorney, one must be a representative of the local district attorney’s office and one must be a representative of the City Attorney’s office. Two members will be chosen by the original petitioners behind the decriminalization ballot measure.
“Our target is to have Denver set a precedent for the rest of the country and be an example for what successful implementation of a psilocybin decriminalization initiative looks like in a city,” Kevin Matthews, who led the successful Decriminalize Denver campaign, told Marijuana Moment in an interview.
While the ballot measure mandated that the review panel be formed by December 31, Matthews said that the mayor’s office is following through with the campaign’s request to move ahead sooner and have members in place by the end of October.
“In many ways implementing the review panel is the most important part of what we accomplished last May,” he said, adding that the early formation of the body “is an example of the work we’re doing here in Denver and what’s possible for the future.”
1. Elect a chairperson and meet at least quarterly or more frequently as necessary;
2. By the March 31 immediately following the adoption of the ballot measure, establish reporting criteria for the Denver Police Department, the Denver Sheriff Department and Denver City Attorney’s Office to report psilocybin mushroom arrests and prosecutions;
3. Submit a comprehensive written report with recommendations to the City Council that will include, but not be limited to, information concerning the public safety, public administration, public health and fiscal impacts of the measure. This report must be completed and presented at the first available City Council Committee Meeting for calendar year 2021.
Members will serve three-year terms and won’t be compensated.
People can apply for a position on the board via the city’s website.
Rather than take one of the two seats to be chosen by the decriminalization campaign, Matthews said he will ask the mayor to appoint him to an additional non-voting ex officio slot so that the formal spaces can go to an attorney and medical doctor with relevant expertise.
He said he hopes the panel will explore broader issues beyond the basic matter of how psilocybin-related arrests will presumably decline in the wake of the ballot measure’s passage.
The vote, he said, “sparked a broader conversation about our city’s enforcement policies when it comes to drug offenders” and that the campaign has already had conversations with the district attorney’s office and mayor’s team about “behavioral health in general.”
Calling Denver a “microcosm of the global mental health and addiction crisis,” Matthews said he wants to “utilize this panel to really start to explore what’s possible in terms of psilocybin therapy’s being an integral part of Denver’s healthcare system.”
“My hope is that we can explore some of these broader issues,” he said.
Denver’s historic decriminalization vote set off a surge of similar initiatives across the country. Following the campaign’s success, Oakland’s City Council unanimously approved a measure to decriminalize not just psilocybin but a host of psychedelics that may hold therapeutic potential in the treatment of various mental health conditions.
Decriminalize Denver, which led the city’s decriminalization initiative, has since morphed into SPORE, a national advocacy group that’s collaborating with activists across the country to reduce criminal penalties for psychedelics offenses.
Photo courtesy of Wikimedia/Mushroom Observer.
New York Legal Marijuana Push ‘Effectively Over’ For 2020, Governor Says
New York Gov. Andrew Cuomo (D) conceded on Saturday that it’s unlikely marijuana will be legalized in the state this year.
“Marijuana and the gig economy were two of the more complicated initiatives that we wanted to work through that we didn’t get a chance to do,” he said in response to a question about which policy issues he would’ve liked to tackle in the annual budget bill that passed this week.
“Is the session effectively over? It’s up to the legislature, but I think it’s fair to say it’s effectively over,” he added, noting that several state lawmakers have been infected with coronavirus.
(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)
Congresswoman Wants Ban On DC Marijuana Sales Lifted Through Coronavirus Legislation
A congresswoman is calling on the government to end a policy prohibiting Washington, D.C. from legal marijuana sales, arguing that the jurisdiction is in particular need of tax revenue from cannabis commerce due to the coronavirus outbreak.
Rep. Eleanor Holmes Norton (D-DC) has repeatedly condemned the congressional rider barring the District of Columbia from allowing retail sales that has been extended each year since 2014, shortly after local voters approved a ballot measure to legalize low-level possession and home cultivation. But given the need for resources to combat the pandemic, she said a reversal of the provision should be included in the next COVID-related relief bill.
“At this moment of unparalleled need, D.C. should be able to collect tax revenue from all available sources, like every other jurisdiction, including from recreational marijuana, which is believed to be widely used in the District,” the congresswoman said in a press release on Friday, adding that D.C. was shorted in the last stimulus because Congress treated it as a territory rather than a state.
“While I am working for a retroactive fix in the next coronavirus bill, it is imperative that Congress also repeal the D.C. recreational marijuana commercialization rider in the next bill to help D.C. shore up its finances,” she said. “It is beyond unreasonable that congressional interference keeps only the District from commercializing recreational marijuana, while all other jurisdictions are free to do so.”
— Eleanor Holmes Norton (@EleanorNorton) April 3, 2020
“Bringing the District in line with other jurisdictions would create a critical source of tax revenue in our time of need.”
Last year, the House approved an appropriations bill that excluded the D.C. rider, but it was included in the Senate version and ultimately made its way into the final package that the president signed. The cannabis commerce ban was also included in President Trump’s budget proposal earlier this year.
“True to form, Representative Eleanor Holmes Norton continues to be one of the best allies to the cannabis reform movement,” Justin Strekal, political director for NORML, told Marijuana Moment. “During this unprecedented COVID-19 outbreak, it is critical that lawmakers analyze and reform any and every aspect of public policy to mitigate the health crisis and build a foundation for a strong recovery.”
“As the majority of states that regulate cannabis have deemed the industry essential to the continued functioning of their jurisdictions, the continued congressional prohibition of the District of Columbia enacting it’s own adult-use program becomes even more ridiculous,” he added.
Norton, in an interview about her push, said that the congressionally mandated prohibition on sales doesn’t prevent people from accessing cannabis but does block the city from collecting tax revenue.
“You can buy two ounces but, by the way you’ve got to do that on the black market,” she told WUSA-TV. “But there’s nobody to tax it. And I’m simply trying to get the taxes the District is due for merchandise, in this case marijuana that’s being consumed readily in the District of Columbia.”
🟢🟢 LEGALIZING COMMERCIAL MARIJUANA IN D.C. 🟢🟢
I spoke to D.C.'s Delegate @EleanorNorton
She's pushing for fully legal commercial marijuana sales in the District in a 4th Congressional stimulus package.
The District needs the money.
And people are smoking weed anyway. pic.twitter.com/PL9yoDKlrj
— Adam Longo (@adamlongoTV) April 3, 2020
Legislative priorities for Congress have shifted significantly as lawmakers attempt to address the outbreak, and that’s meant putting some reform efforts on hold. However, the issue isn’t being ignored entirely, and it’s possible that other members may look to attach modest marijuana proposals to additional coronavirus legislation.
For example, Rep. Katherine Clark (D-MA) said this week that U.S. Department of Veterans Affairs policy preventing its doctors from recommending medical cannabis in legal states puts service members at risk in Massachusetts because the state is shuttering recreational shops (but not medical dispensaries) and some veterans fear registering as patients out of concern that they could lose federal benefits.
Eleven senators wrote a letter to Appropriations Committee leadership asking that they allow small cannabis businesses to access federal loans and disaster relief programs. While the lawmakers said it should be enacted through an annual spending bill, advocates have argued that the policy change should be pursued through coronavirus legislation since these businesses are facing challenges just like those experienced by many other companies during the pandemic.
Photo courtesy of WeedPornDaily.
North Dakota Activists Say Marijuana Legalization Initiative Unlikely In 2020 Due To Coronavirus
North Dakota activists announced on Thursday that they are suspending their campaign put marijuana legalization on the November ballot due to the coronavirus outbreak.
In a Facebook post, Legalize ND said “we are going to have to face a few hard realities going forward” as businesses are shuttering, public events are being cancelled and individuals are encouraged to shelter in place. The pandemic means in-person signature gathering can’t take place, and the state does not allow for alternative signing options such as by mail or online.
“Due to the virus all of our major avenues for signature collection have been cancelled or indefinitely postponed, and going door to door is not safe for both those knocking and those getting knocked,” the group said. “Businesses will continue to collect, but we don’t want to create another vector for the coronavirus. As a result, at this time if something major doesn’t change we will not be able to make the 2020 ballot.”
Legalize ND said there’s no way for state policies related to signature gathering to be changed ahead of the November election. They needed to collect 13,452 valid signatures from voters before July 6 in order to qualify. In all likelihood, the campaign said it would have to shift its focus to the July 2022 primary election.
“This isn’t the solution we want, but given the situation it is what will have to happen,” the post states. “Stay safe, and hopefully we can make a major push when the quarantine ends.”
The proposed initiative would allow individuals to purchase and possess up to two ounces of cannabis. Unlike a much more far-reaching measure the same group pushed in 2018 that included no possession or cultivation limits, which voters rejected, this version would prohibit home growing, impose a 10 percent excise tax and establish a regulatory body to approve licenses for marijuana businesses.
North Dakota voters approved a medical cannabis initiative in 2016.
The coronavirus outbreak has dealt several blows to drug policy reform efforts in recent weeks.
Likewise in Washington, D.C., advocates for a measure to decriminalize psychedelics asked the mayor and local lawmakers to accept online signatures for their ballot petition.
In Oregon, advocates for a measure to decriminalize drug possession and a separate initiative to legalize psilocybin for therapeutic purposes have suspended in-person campaign events amid the pandemic.
In New York, Gov. Andrew Cuomo (D) recently conceded that legalization was “not likely” going to happen through the budget, as he hoped. Coronavirus shifted legislative priorities, and comprehensive cannabis reform seems to have proved too complicated an issue in the short-term.
Idaho activists announced on Thursday that they are suspending their campaign, though they are still “focusing on distributing petitions through online download at IdahoCann.co and encouraging every volunteer who has downloaded a petition to get them turned in to their county clerk’s office by mail, regardless of how many signatures they have collected.”
Finally, in Arizona, a legalization campaign is petitioning the state Supreme Court to instruct the secretary of state to allow individuals to sign ballot petitions digitally using an existing electronic system that is reserved for individual individual candidates seeking public office.
Photo courtesy of Philip Steffan.